The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Clesrovimab is a single-dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Credit: Sergiy Palamarchuk ...

The trial demonstrated a median reduction in EEG seizure burden Credit: Ground Picture/Shutterstock. Marinus Pharmaceuticals has reported results from the pivotal Phase III RAISE trial for intravenous ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

BMS and 2seventy bio decided to halt the KarMMa-9 study, which is said to be influenced by the evolving treatment landscape for NDMM. Credit: Bristol-Myers Squibb Company. Bristol Myers Squibb (BMS) ...

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical ...

NovoCure’s Optune Lua, a wearable indicated for patients with metastatic non-small cell lung cancer has received approval ...

Genprex received approval to proceed to the highest dose in the Phase I Acclaim-3 trial of Reqorsa for ES-small cell lung ...

The upcoming two-day event delves into the clinical trial landscape and the strategies employed to increase the region’s ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) expects the new UK clinical trial regulation to be ...